Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.69 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.44 |
| ▸ | SCN1A | P35498 | 2/20 | 0.44 |
| ▸ | SCN4A | P35499 | 2/20 | 0.44 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.44 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.44 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.44 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.44 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.44 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | SCN7A | Q01118 | 1/20 | 0.44 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.44 |
| ▸ | SCN11A | Q9UI33 | 1/20 | 0.44 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.44 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26664974 | 1.00 | CYP19A1 (0.69) | CYP19A1CACNA1FSCN1ASCN4ACACNA1D | |
| SCHEMBL15196027 | 1.00 | CYP19A1 (0.69) | CYP19A1CACNA1FSCN1ASCN4ACACNA1D | |
| SCHEMBL2054565 | 1.00 | CYP19A1 (0.69) | CYP19A1CACNA1FSCN1ASCN4ACACNA1D | |
| SCHEMBL14520901 | 0.83 | CYP19A1 (0.72) | CYP19A1KCNH2MAOBMAOACXCR3 | |
| SCHEMBL4556388 | 0.83 | CYP19A1 (0.72) | CYP19A1KCNH2MAOBMAOACXCR3 | |
| SCHEMBL10530071 | 0.81 | CYP19A1 (1.00) | CYP19A1ALDH1A1 | |
| SCHEMBL8245665 | 0.81 | CYP19A1 (0.70) | CYP19A1MMP2MMP9KDM1ACXCR3 | |
| SCHEMBL22623727 | 0.81 | CYP19A1 (1.00) | CYP19A1ALDH1A1 | |
| SCHEMBL10530941 | 0.81 | CYP19A1 (1.00) | CYP19A1ALDH1A1 | |
| SCHEMBL13201868 | 0.81 | CYP19A1 (0.70) | CYP19A1MMP2MMP9KDM1ACXCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119579143-A | Intelligent paint production full-flow monitoring and optimizing system, method and medium | 广东卓和高新材料有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-116078359-A | Multilayer film of graphene oxide-polymer microgel and preparation method and application thereof | 中国人民解放军空军军医大学 | 2023-05-09 | — | — | CN | claimed |
| US-12605450-B2 | C3-carbon linked glutarimide Degronimers for target protein degradation | C4 THERAPEUTICS, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| CN-119579143-A | Intelligent paint production full-flow monitoring and optimizing system, method and medium | 广东卓和高新材料有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119432998-A | Kit for detecting phenylketonuria pathogenic gene and application thereof | 郑州大学第三附属医院(河南省妇幼保健院) | 2025-02-14 | — | — | CN | disclosed |
| US-20240398959-A1 | C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION | C4 THERAPEUTICS, INC. (US) | 2024-12-05 | — | — | US | disclosed |
| CN-118103436-A | Depolymerization of polyhydroxyalkanoates and recovery of the polyhydroxyalkanoate monomers obtained by metabolic processes | 金伯利-克拉克环球有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-11992531-B2 | C3-carbon linked glutarimide degronimers for target protein degradation | C4 THERAPEUTICS, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| US-11974977-B2 | Composition and uses for influencing hair growth | LUCOLAS—M.D. LTD (GB) | 2024-05-07 | — | — | US | disclosed |
| US-20230234950-A1 | CRBN LIGANDS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-07-27 | — | — | US | disclosed |
| US-20230234950-A1 | CRBN LIGANDS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-07-27 | — | — | US | disclosed |
| US-4839379-A | AROMATASE INHIBITORS | CIBA-GEIGY CORPORATION (US) | 1989-06-13 | — | — | US | disclosed |
| EP-0114033-B1 | SUBSTITUTED AZABICYCLOALKANES, THEIR USE, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THESE COMPOUNDS | CIBA-GEIGY AG (CH) | 1988-10-12 | — | — | EP | disclosed |
| EP-0114033-A1 | Substituted azabicycloalkanes, their use, pharmaceutical preparations containing these compounds and process for preparing these compounds | CIBA-GEIGY AG (CH) | 1984-07-25 | — | — | EP | disclosed |
| EP-0114033-A1 | Substituted azabicycloalkanes, their use, pharmaceutical preparations containing these compounds and process for preparing these compounds | CIBA-GEIGY AG (CH) | 1984-07-25 | — | — | EP | disclosed |
| US-4435419-A | Method of treating depression using azabicyclohexanes | AMERICAN CYANAMID COMPANY (US) | 1984-03-06 | — | — | US | disclosed |
| US-4231935-A | ANXIOLYTICS AND ANALGESICS | AMERICAN CYANAMID COMPANY (US) | 1980-11-04 | — | — | US | disclosed |
| US-4196120-A | 1,2-BIS(HYDROCARBYLSULFONYLOXY OR HALO METHYL)CYCLOPROPYLBENZENE, OPTICAL ACITIVITY ANALGESICS | AMERICAN CYANAMID COMPANY (US) | 1980-04-01 | — | — | US | disclosed |
| US-4131611-A | ANXIOLYTIC, ANALGESIC | AMERICAN CYANAMID COMPANY (US) | 1978-12-26 | — | — | US | disclosed |
| US-4088652-A | Acylazabicyclohexanes | AMERICAN CYANAMID COMPANY (US) | 1978-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234950-A1 | CRBN LIGANDS AND USES THEREOF | CRBN, CRKL, ERBB3 | CYP19A1 3947/4885CACNA1F 3739/4885SCN1A 4340/4885 |
| US-12605450-B2 | C3-carbon linked glutarimide Degronimers for target protein degradation | NEDD4, UBE3A, UBE3C | CYP19A1 2859/4885CACNA1F 4600/4885SCN1A 1316/4885 |
| US-11992531-B2 | C3-carbon linked glutarimide degronimers for target protein degradation | STUB1, UBE3C, UBE3A | CYP19A1 1336/4885CACNA1F 4810/4885SCN1A 4754/4885 |
| US-20240398959-A1 | C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION | STUB1, UBE3C, UBE3A | CYP19A1 1336/4885CACNA1F 4810/4885SCN1A 4754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.